International Biotechnology (LON:IBT - Get Free Report) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 630.43 ($8.50) and traded as high as GBX 632 ($8.53). International Biotechnology shares last traded at GBX 626 ($8.44), with a volume of 240,274 shares changing hands.
International Biotechnology Price Performance
The stock's fifty day moving average is GBX 589.41 and its 200-day moving average is GBX 630.43. The stock has a market cap of £227.02 million, a PE ratio of 6.03 and a beta of 0.21.
International Biotechnology (LON:IBT - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported GBX (5.60) (($0.08)) earnings per share for the quarter. International Biotechnology had a net margin of 90.66% and a return on equity of 13.67%. On average, sell-side analysts expect that International Biotechnology will post 0.9435943 EPS for the current fiscal year.
Insiders Place Their Bets
In other International Biotechnology news, insider Katherine Cornish-Bowden bought 2,000 shares of the business's stock in a transaction on Tuesday, May 13th. The stock was bought at an average price of GBX 585 ($7.89) per share, with a total value of £11,700 ($15,783.08). Insiders own 4.18% of the company's stock.
About International Biotechnology
(
Get Free Report)
The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Featured Articles
Before you consider International Biotechnology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.
While International Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
